This fall, an emerging talent in the art world–and a woman with epilepsy–will have a solo exibition in Philadelphia.
Cathy Hozack on being an artist
“I’ve had epilepsy since I was five. The seizures and strong medications made me tired, confused, depressed and out of touch with reality. Over time, parts of my memory have gotten worse, but I can concentrate when using watercolors. I pick up a brush and the problems no longer matter. What I learned in Color Theory class is ingrained in my mind forever – but I have forgotten your name already.
I express my strongest feelings on paper and canvas. How I record the world around me depends on my mood and on what is going through my mind. I want to show everyone how I see the world around us.”- Cathy Hozack, October 2008
To experience her art in person:
Cathy Hozack – Solo Exhibition
The Coffee Bar
Radisson Plaza – Warwick Hotel
1701 Locust Street, Philadelphia, PA 19103
Opening Reception
Wednesday, September 23, 6 to 8pm
Exhibition Dates
September 16 through December 14, 2009
To see her work online visit cathyhozack.com
Jessica Keenan Smith is a patient advocate and epilepsy community leader with more than 15 years of experience. As Founder and CEO of Living Well With Epilepsy and Executive Director of ASENT she bridges the gap between the scientific and patient communities, with a particular focus on the needs of the epilepsies. Jessica Keenan Smith is Founder and CEO of Living Well With Epilepsy, an award winning online resource for people affected by epilepsy to share stories and access in-depth information on the disease. Since 2009, Living Well With Epilepsy (https://livingwellwithepilepsy.com) has been featured in Forbes, Wired, NBC, NPR and the cover story of Epilepsy Advocate Magazine and has partnered with companies such as UCB, Lundbeck, Sunovion, Eisai, and more. Ms. Smith is also the Executive Director of the American Society for Experimental Neurotherapeutics (ASENT) (https://asent.org), an organization that brings together leaders from industry, academia, government and advocacy who are engaged in bringing drugs and devices to market across all neurologic disease states. In this role she is responsible for leading a successful scientific journal and annual scientific conference with speakers from all over the world.
Leave a Reply